The KRAS expression signature, developed from a mouse tumor model, was shown to be significantly enriched in KRAS mutated human lung adenocarcinoma data sets by a rank order-based statistical test to detect subtle but significant similarity hidden in genome-scale profiles [29]. This evidence concerns the gene KRAS and neoplasm.